Moneycontrol
HomeNewsBusinessAmerican Express pledges Rs 9 crore to combat COVID-19 outbreak in India
Trending Topics

American Express pledges Rs 9 crore to combat COVID-19 outbreak in India

"Rs 9 crore has been committed in various forms of financial support to back the tireless work of those on the front lines of this global crisis," the company said in a statement.

June 11, 2020 / 20:57 IST
Story continues below Advertisement

Credit card issuer American Express on June 11 said it has pledged Rs 9 crore for combating the COVID-19 pandemic in India.

"Rs 9 crore has been committed in various forms of financial support to back the tireless work of those on the front lines of this global crisis," the company said in a statement.

Story continues below Advertisement

This includes contributions to the Prime Minister's Citizen Assistance and Relief in Emergency Situations Fund (PM CARES) as well as to local organisations in India, it said.

The grants will help provide protective equipment to frontline healthcare workers, support the development of vaccines and research and help feed people impacted in our communities, among other critical needs, it added.

COVID-19 Vaccine
Frequently Asked Questions

View more

How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.
View more
+ Show